
Misty Shields, MD, PhD, is a thoracic medical oncologist and physician-scientist. She serves as Assistant Professor of Clinical Medicine at the Indiana University School of Medicine and is an associate member of the Experimental and Developmental Therapeutics program at the IU Melvin and Bren Simon Comprehensive Cancer Center, where she leads the Shields Laboratory. Her clinical focus includes thoracic oncology, hematologic oncology, and early-phase oncology care. Her research centers on translational therapeutics for chemo-resistant small cell lung cancer, liquid biopsy–based monitoring and biomarker discovery, and first-in-human and phase I drug development. Dr. Shields contributes to national and community leadership as a member of the National Comprehensive Cancer Network guideline panel for small cell lung cancer and the local leadership board of the American Lung Association. She serves as a clinical trials advocate for the IU Simon Comprehensive Cancer Center’s End Lung Cancer Now initiative and founded Small Cell SMASHERS in partnership with the Lungevity Foundation. During fellowship, she served as chief fellow. She earned her MD from the University of Texas Health Houston McGovern Medical School and completed internal medicine residency at Vanderbilt University Medical Center. She completed a hematology/oncology fellowship at the University of South Florida/Moffitt Cancer Center, where she served as chief fellow. She also holds a PhD from the University of Texas Southwestern Medical Center and completed a post-doctoral fellowship there.
Assistant Professor
Medical School
Residency
Fellowship